Brainstorm reschedules first quarter 2025 financial results release to post-market close today and sets investor call for monday, may 19

New york , may 15, 2025 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it has rescheduled the release of its financial results for the first quarter ended march 31, 2025, to post-market close today, may 15. in addition, the company has rescheduled its previously announced investor conference call, which will now take place on monday, may 19, 2025, at 8:30 a.m.
BCLI Ratings Summary
BCLI Quant Ranking